Article
RECK gene polymorphisms influence NSCLC susceptibility, but not the chemotherapy response status in Chinese cohort.
Cell biochemistry and biophysics - 1 Jul 2014
Chen Xiaohui, Jiang Fusheng, Shi Ningchuan, Zhou Hui, Zhang Liang, Chen Yu, Zheng Yanhua, Yan Tian Guo
Abstract excerpt
To test the possible association between reversion-inducing cysteine-rich protein with Kazal motifs (RECK) genetic variants and susceptibility as well as the chemotherapy response status to in patients with advanced non-small cell lung cancer (NSCLC). We recruited 304 patients who were histologically diagnosed as advanced NSCLC (IIIa, IIIb, and IV stage) in our hospital from September 2003 to January 2008. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
